CryoPort Inc (NASDAQ:CYRX)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $30.34 and last traded at $29.96, with a volume of 250754 shares trading hands. The stock had previously closed at $28.93.
A number of brokerages have commented on CYRX. B. Riley reissued a “buy” rating and issued a $24.00 price objective on shares of CryoPort in a research note on Tuesday, April 7th. SVB Leerink lifted their price target on CryoPort from $24.00 to $25.00 and gave the stock an “outperform” rating in a report on Friday, May 8th. Roth Capital lifted their price target on CryoPort from $25.00 to $30.00 in a report on Monday, May 11th. BidaskClub upgraded CryoPort from a “buy” rating to a “strong-buy” rating in a report on Friday, May 15th. Finally, Zacks Investment Research lowered CryoPort from a “buy” rating to a “hold” rating in a report on Friday, May 8th. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. CryoPort presently has an average rating of “Buy” and an average target price of $24.67.
The company has a market capitalization of $1.15 billion, a PE ratio of -52.81 and a beta of 0.83. The company has a quick ratio of 14.79, a current ratio of 14.86 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average price of $24.99 and a two-hundred day moving average price of $19.25.
CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Thursday, May 7th. The consumer goods maker reported ($0.11) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.06). The company had revenue of $9.80 million during the quarter, compared to analysts’ expectations of $9.76 million. CryoPort had a negative net margin of 53.66% and a negative return on equity of 16.83%. CryoPort’s revenue for the quarter was up 48.5% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.08) earnings per share. As a group, equities analysts anticipate that CryoPort Inc will post -0.34 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently made changes to their positions in CYRX. Oppenheimer Asset Management Inc. grew its position in shares of CryoPort by 80.1% in the first quarter. Oppenheimer Asset Management Inc. now owns 1,650 shares of the consumer goods maker’s stock valued at $28,000 after purchasing an additional 734 shares in the last quarter. Great West Life Assurance Co. Can purchased a new position in shares of CryoPort in the fourth quarter valued at $41,000. Advisor Group Holdings Inc. purchased a new position in CryoPort during the first quarter worth about $62,000. PNC Financial Services Group Inc. purchased a new position in CryoPort during the first quarter worth about $70,000. Finally, First Mercantile Trust Co. grew its position in CryoPort by 14.7% during the first quarter. First Mercantile Trust Co. now owns 8,481 shares of the consumer goods maker’s stock worth $145,000 after buying an additional 1,088 shares in the last quarter. Institutional investors own 84.17% of the company’s stock.
About CryoPort (NASDAQ:CYRX)
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
See Also: Arbitrage
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.